Welcome to our dedicated page for L3Harris Technologies SEC filings (Ticker: LHX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
L3Harris Technologies filings document operating results, material events, governance and capital structure for a defense technology company with a three-segment reporting structure. Recent 8-K reports furnish earnings releases and describe segment leadership changes, officer appointments, compensation arrangements and the reorganization of business segments.
Other disclosures cover preferred stock and warrant financing at Aerojet Rocketdyne Holdings, registration rights, executive trading-plan matters under Rule 10b5-1, and related Form 4 or Form 144 reporting. The definitive proxy statement addresses board elections, executive compensation, shareholder voting matters and governance practices.
Form 144 filed for L3Harris Technologies (LHX) shows an insider notice to sell 40,138 shares on 08/11/2025 on the NYSE, with an aggregate market value of $10,818,005.61. The filing identifies the seller in recent sale history as Christopher E. Kubasik and reports that the securities to be sold were acquired under an option granted on 12/20/2017 from the issuer, with payment in cash on 08/11/2025.
The filing also discloses three sales by Christopher E. Kubasik in the prior three months totaling 107,273 shares for $28,282,910.76 (sales on 06/11/2025, 06/12/2025 and 07/29/2025). The 40,138-share notice represents approximately 0.0215% of the 187,094,798 shares outstanding reported in the form; the prior three months' sales represent approximately 0.0573% of outstanding shares. The signer certifies no undisclosed material adverse information is known.
Form 4 highlights: On 07/29/2025 L3Harris Technologies (LHX) Chair & CEO Christopher E. Kubasik exercised 72,000 non-qualified stock options at an exercise price of $149.31 and simultaneously sold 72,000 common shares in the open market at a weighted-average price of $271.14 (range $269.92-$272.31). Following the transactions he now owns 145,577.82 shares directly and 30,000 shares indirectly through a grantor retained annuity trust.
The option, originally exercisable since 06/29/2019 and expiring 12/20/2027, was converted under code “M” (option exercise) and immediately disposed under code “S” (sale). The filing indicates routine reporting under Section 16 with no other derivative activity disclosed. Kubasik remains both a Director and the company’s Chair & CEO.
Key take-away: While the same-day sale represents sizeable insider monetization, the executive retains a meaningful equity stake that may continue to align his interests with shareholders.